Fundraising FoxBrain Trust Accelerator Fund
Impact investorBurlingame · Seed–Series A · 1 people tracked
Find your way into Brain Trust Accelerator Fund
Each arrow is one introduction. Sign up to fill in the first one.
Ask Ryan Kraus to introduce you to John M. Reher
You →Ryan · together at Orange Digital Ventures →John
Sign up to find every way you can get introduced to Brain Trust Accelerator Fund
- Your email: who you already know at Brain Trust Accelerator Fund, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Brain Trust Accelerator Fund team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
The Brain Trust Accelerator Family of Funds invests in translational-stage opportunities aimed at improving the diagnosis and treatment of brain-related diseases, framing its work as impact investing in brain disease. The firm reports that its first fund generated top-tier returns, supported approaches with the potential to benefit up to ten million patients with brain diseases, and directed $500,000 to charities. It expresses similar optimism about the prospects for its second fund.
Source: firm website, verified Sep 27, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×2AI & Machine Learning ×1Digital Health ×1Medical Devices ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2016 · 12010 · 12 dated
NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCleveland, US
Co-investorsDolby Family Ventures
Irvine, CA based Alzheimer's drug company
BiotechWashington, US
Thomas N. Chase(Executive Officer, Director)Douglas Ingram(Executive Officer, Director)John M. Siebert(Executive Officer, Director)Kathleen Clarence-Smith(Executive Officer)
BoardNayan Greg Parekh(Director)
Board seatJohn M. Reher· per SEC Form D · $612.5K raise · filed Feb 2016
Co-investorsAndera PartnersNew Rhein Healthcare Investors, LLC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Brain Trust Accelerator Fund invest at?
- Brain Trust Accelerator Fund invests at the Seed, Series A stages.
- What sectors does Brain Trust Accelerator Fund focus on?
- Brain Trust Accelerator Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Brain Trust Accelerator Fund located?
- Brain Trust Accelerator Fund is headquartered in Burlingame, US.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity.
EMV Capital is a deep tech and life sciences venture capital investment group that invests in, strengthens, and manages early-stage companies with attractive intellectual property. It uses a capital-efficient model combining syndicated investments, balance sheet stakes, and fund deployment.
Asabys Partners is an investment firm based in Barcelona focused on healthcare and life-sciences innovation.